Citadel Advisors’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-33,972
| Closed | -$389K | – | 14077 |
|
|
2020
Q4 | $389K | Buy |
33,972
+23,893
| +237% | +$272K | ﹤0.01% | 8625 |
|
|
2020
Q3 | $69K | Buy |
+10,079
| New | +$66.2K | ﹤0.01% | 9474 |
|
|
2020
Q2 | – | Sell |
-18,117
| Closed | -$120K | – | 10829 |
|
|
2020
Q1 | $120K | Buy |
+18,117
| New | +$158K | ﹤0.01% | 8497 |
|
|
2019
Q1 | – | Sell |
-22,061
| Closed | -$254K | – | 10150 |
|
|
2018
Q4 | $254K | Sell |
22,061
-1,343
| -6% | -$22.9K | ﹤0.01% | 7523 |
|
|
2018
Q3 | $506K | Sell |
23,404
-104,878
| -82% | -$1.98M | ﹤0.01% | 6669 |
|
|
2018
Q2 | $2.02M | Buy |
128,282
+115,915
| +937% | +$1.82M | ﹤0.01% | 4093 |
|
|
2018
Q1 | $233K | Sell |
12,367
-41,887
| -77% | -$826K | ﹤0.01% | 7112 |
|
|
2017
Q4 | $944K | Buy |
54,254
+40,917
| +307% | +$565K | ﹤0.01% | 4733 |
|
|
2017
Q3 | $200K | Buy |
+13,337
| New | +$210K | ﹤0.01% | 6698 |
|
|
2016
Q4 | – | Sell |
-40,377
| Closed | -$738K | – | 8096 |
|
|
2016
Q3 | $738K | Buy |
40,377
+16,987
| +73% | +$383K | ﹤0.01% | 4255 |
|
|
2016
Q2 | $678K | Buy |
+23,390
| New | +$651K | ﹤0.01% | 4081 |
|
Citadel Advisors's ARA Position: Q1 2021 in Review
Citadel Advisors sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 33,972 shares — an estimated $389K sold.
Citadel Advisors first reported a position in ARA in Q2 2016 and held it in 11 quarters. The position peaked at $2.02M in Q2 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Citadel Advisors reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Citadel Advisors sold 33,972 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $389K.
- Citadel Advisors first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 11 quarters.
- Citadel Advisors's American Renal Associates Holdings, Inc position peaked at $2.02M in Q2 2018.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.